Trial Profile
Phase Ia trial investigating the safety and pharmacokinetics of epalrestat [NM-IA-001] in patients with diabetic polyneuropathy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jun 2013
Price :
$35
*
At a glance
- Drugs Diepalrestat choline (Primary)
- Indications Diabetic neuropathies
- Focus Adverse reactions; Pharmacokinetics
- 04 Jun 2013 New trial record